Aptamer Group (APTA LN)

Analysis

Health Care • United Kingdom

Aptamer Group Plc is a biotechnology company that provides Optimer binders for use in research, diagnostics, and therapeutics. The company utilizes its proprietary Optimer technology to offer custom development services for oligonucleotide-based binders, aiming to deliver transformational solutions across the life sciences industry. Aptamer Group was founded in 2008 and is headquartered in York, United Kingdom.

Refresh

Exchange Announcement • 13 Oct 2026 13:00

Full Year Results for the 12mths to 30 June 2026

Exchange Announcement • 07 Oct 2026 13:00

Notice of Results, Analyst & Investor Presentation

Exchange Announcement • 20 Aug 2026 13:00

Appointment of Joint Corporate Broker

Exchange Announcement • 14 Aug 2026 13:00

Director Fee Shares and Grant of Options

Exchange Announcement • 13 Jul 2026 13:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Full Year Results for the 12mths to 30 June 2026

Notice of Results, Analyst & Investor Presentation

Appointment of Joint Corporate Broker

Director Fee Shares and Grant of Options

Trading Update